University of Florida’s Dr. Mansour Mohamadzadeh has received a $100 thousand grant from the Florida Breast Cancer Foundation (FBCF) to investigate new treatment strategies that leverage the use of a synthesized propionibacterium to combat breast cancer. The award, part of the highly competitive FBCF Research Grant program, is part of the FBCF’s initiative to fund multi-disciplinary collaborations with the potential to make a significant impact in the fight against breast cancer.
The grant will allow Dr. Mohamadzadeh, a professor of mucosal immunology at the University of Florida’s Department of Medicine and Veterinary Medicine (respectively), and his research team to continue to build upon their groundbreaking discovery of their synthesized Propionibacterium, dubbed P. UF1, and its ability to bolster host immune responses and combat diseases and maladies that are detrimental to human health.
Founded in 1993, the Florida Breast Cancer Foundation began as a grassroots non-profit organization devoted to ending breast cancer through education, advocacy, and supporting scientific research. The FBCF works statewide to raise awareness and mobilize Floridians to ensure sufficient public funding for breast cancer research and quality healthcare for those afflicted by the disease.
To learn more about the Florida Breast Cancer Foundations programs, please visit https://www.floridabreastcancer.org/our-programs